Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-02-14 | Mr. Mark MosslerCAO | 6,15k | 0,00 | Derivative Exercise and Retained Stock | - | 5,79k | -1.704,16% |
| 2026-02-14 | Mr. Mark MosslerCAO | -3,27k | 6,18k | Derivative Exercise and Sale | 1,89 | 5,79k | - |
| 2026-02-14 | Dr. Leonard M. J. ReynoChief Medical Officer | 14,37k | 0,00 | Derivative Exercise and Retained Stock | - | 25,48k | 129,39% |
| 2026-02-14 | Dr. Leonard M. J. ReynoChief Medical Officer | -16,58k | 31,33k | Derivative Exercise and Sale | 1,89 | 25,48k | - |
| 2026-02-13 | Mr. Scott N. BoyleChief Business Officer | 16,95k | 0,00 | Derivative Exercise and Retained Stock | - | 37,78k | 81,35% |
| 2026-02-13 | Mr. Scott N. BoyleChief Business Officer | -9,00k | 17,02k | Derivative Exercise and Sale | 1,89 | 37,78k | - |
| 2026-02-13 | Ms. Kelly A. SchickCPO | 16,95k | 0,00 | Derivative Exercise and Retained Stock | - | 38,86k | 77,34% |
| 2026-02-13 | Ms. Kelly A. SchickCPO | -9,00k | 17,02k | Derivative Exercise and Sale | 1,89 | 38,86k | - |
| 2026-02-14 | Ms. Paige MahaneyChief Scientific Officer | 4,60k | 0,00 | Derivative Exercise and Retained Stock | - | 18,16k | 33,96% |
| 2026-02-14 | Ms. Paige MahaneyChief Scientific Officer | -2,45k | 4,62k | Derivative Exercise and Sale | 1,89 | 18,16k | - |
| 2026-02-14 | Mr. Andrew J. HirschCEO, President & Director | 53,91k | 0,00 | Derivative Exercise and Retained Stock | - | 135,21k | 66,32% |
| 2026-02-14 | Mr. Andrew J. HirschCEO, President & Director | -48,21k | 91,12k | Derivative Exercise and Sale | 1,89 | 135,21k | - |
| 2026-02-13 | Ms. Kendra R. AdamsCFO and Head of Corporate Affairs & Treasurer | 17,46k | 0,00 | Derivative Exercise and Retained Stock | - | 45,17k | 62,98% |
| 2026-02-13 | Ms. Kendra R. AdamsCFO and Head of Corporate Affairs & Treasurer | -17,24k | 32,59k | Derivative Exercise and Sale | 1,89 | 45,17k | - |
| 2026-01-16 | Dr. Leonard M. J. ReynoChief Medical Officer | -10,00k | 22,20k | Verkauf | 2,22 | 11,11k | -47,38% |
| 2025-10-28 | Ms. Paige MahaneyChief Scientific Officer | 13,56k | 0,00 | Derivative Exercise and Retained Stock | - | 13,56k | - |
| 2025-10-28 | Ms. Paige MahaneyChief Scientific Officer | -5,64k | 14,56k | Derivative Exercise and Sale | 2,58 | 13,56k | - |
| 2025-09-18 | Ms. Kendra R. AdamsCFO and Head of Corporate Affairs & Treasurer | 3,48k | 0,00 | Derivative Exercise and Retained Stock | - | 27,72k | 14,33% |
| 2025-09-18 | Ms. Kendra R. AdamsCFO and Head of Corporate Affairs & Treasurer | -2,78k | 9,21k | Derivative Exercise and Sale | 3,32 | 27,72k | - |
| 2025-07-10 | Dr. Leonard M. J. ReynoChief Medical Officer | 7,94k | 0,00 | Derivative Exercise and Retained Stock | - | 21,11k | 60,34% |
| 2025-07-10 | Dr. Leonard M. J. ReynoChief Medical Officer | -7,38k | 14,69k | Derivative Exercise and Sale | 1,99 | 21,11k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
